Cercar
12/04/2025
Sex-based differences in Jumping to Conclusions: a multidimensional analysis of first-episode psychosis
Díaz-Cutraro, L, Verdaguer-Rodríguez, M, García-Mieres, H, Ferrer-Quintero, M, López-Carrilero, R, Palma-Sevillano, C, Lamarca, M, Espinosa, V, Barrigón, ML, González-Higueras, F, Pousa, E, Grasa, E, Lorente-Rovira, E, Gutiérrez-Zotes, A, Barajas, A, Ruiz-Delgado, I, Cid, J, Moritz, S, Rico, J, Sevilla-Llewellyn-Jones, J, Haro, JM, Ochoa, S. Sex-based differences in Jumping to Conclusions: a multidimensional analysis of first-episode psychosis. SCHIZOPHRENIA. 2025; 11(1)DOI:10.1038/s41537-025-00579-0. PMID:40221473. IF:4.100(Q1/2D).
01/04/2025
Scale to measure dialectical thinking from dialectical behavior therapy perspective.
Soler, J, Arqueros, M, Schmidt, C, Otero, D, Soria-Madrid, A, Campins, MJ, Catalan, A, Casellas, E, Espeso, R, Pascual, JC. Scale to measure dialectical thinking from dialectical behavior therapy perspective.. EUROPEAN JOURNAL OF PSYCHIATRY. 2025; 39(2)DOI:10.1016/j.ejpsy.2025.100305. PMID:. IF:1.500(Q3/7D).
01/04/2025
Alcohol and Other Substance Screening in Bariatric Surgery Candidates: Utility of Self-Report and Toxicology Tests, Including Ethyl-Glucoronide
Cañizares, S, Nuño, L, Barrio, P, Forner-Puntonet, M, Gavotti, C, Monràs, M, Gavín, P, Navinés, R, Flores, L, Barrios, M, Andreu, A, Molero, J, Jimenez, A, Vidal, J, Lligoña, A. Alcohol and Other Substance Screening in Bariatric Surgery Candidates: Utility of Self-Report and Toxicology Tests, Including Ethyl-Glucoronide. OBESITY SURGERY. 2025; 35(4)DOI:10.1007/s11695-025-07774-z. PMID:40072740. IF:3.100(Q1/2D).
19/03/2025
Insights on the cognitive enhancement effect of desvenlafaxine in major depressive disorder
Vicent-Gil, M, Trujols, J, Sagues, T, Serra-Blasco, M, Navarra-Ventura, G, Mantellini, CL, Crivillés, S, Portella, MJ, Cardoner, N. Insights on the cognitive enhancement effect of desvenlafaxine in major depressive disorder. Annals of General Psychiatry. 2025; 24(1)DOI:10.1186/s12991-025-00552-2. PMID:40108685. IF:3.100(Q2/4D).
07/02/2025
Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness
Cardoner, N, Gutiérrez-Rojas, L, Saiz, P, Lahera, G, alvarez-Mon, MA, Ortega, PA, Pérez-Páramo, M. Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness. Frontiers in Pharmacology. 2025; 16DOI:10.3389/fphar.2025.1483770. PMID:39989902. IF:4.800(Q1/2D).
01/02/2025
Mapping punishment avoidance learning deficits in non-suicidal self-injury in young adults with and without borderline personality disorder: An fMRI study
Nicolaou, S, Pascual, JC, Soler, J, Ortega, G, Marco-Pallarés, J, Vega, D. Mapping punishment avoidance learning deficits in non-suicidal self-injury in young adults with and without borderline personality disorder: An fMRI study. JOURNAL OF AFFECTIVE DISORDERS. 2025; 370DOI:10.1016/j.jad.2024.11.026. PMID:39542117. IF:4.900(Q1/2D).